Table I.
Demographic information about the typically developing (TD) and high‐functioning ASD (HF‐ASD) group
| TD group (N = 15) | HF‐ASD group (N = 14) | |
|---|---|---|
| Age | 15.95 (±1.65) | 15.79 (±1.93) |
| IQ | 104.9 (±8.45) | 106.5 (±20.01) |
| Handedness score | 78.7 (±47.5) | 66.8 (±58.1) |
| Male/female | 13/2 | 10/4 |
| Diagnosis | NA | Autistic disorder (N = 10), Asperger syndrome (N = 4) |
| Social interaction | ||
| ADI‐R scale A (subj. 1–14) | NA | 10‐12‐22‐14‐21‐19‐24‐19‐10‐13‐19‐13‐9‐28 |
| Comunication and language | ||
| ADI‐R scale B (subj. 1–14) | NA | 12‐7‐14‐4‐15‐16‐20‐14‐9‐10‐14‐6‐9‐19 |
| Nonverbal | ||
| ADI‐R scale B N.V. (subj. 1–14) | NA | 10‐6‐9‐1‐10‐7‐14‐10‐6‐6‐8‐4‐6‐16 |
| Repetitive, restricted and stereotyped interests and behavior | ||
| ADI‐R scale C (subj. 1–14) | NA | 0‐1‐5‐5‐5‐4‐3‐3‐0‐1‐6‐4‐9‐8 |
| Other | ||
| ADI‐R scale D (subj. 1–14) | NA | 1‐1‐1‐3‐2‐2‐2‐2‐1‐1‐3‐3‐2‐5 |
| Co‐morbitity | NA | ADHD (N = 2), Gilles de la Tourette (N = 1), dysthemia (N = 1) |
| Medication | NA | Fluoxetine (N = 2), Risperidone (N = 1), Concerta (N = 1) |